Fermenta Biotech Ltd

506414

Overview

    • Equity Style Box

      Small Blend

    • Sector

      Healthcare

    • Industry

      Drug Manufacturers - Specialty & Generic

    • Day Range

      242.10 – 253.00

    • Year Range

      145.00 – 449.00

    • Market Cap

      7.1123 Bil

    • Volume / Avg

      32.1 k / 36.7 k

    • Price / Sales

      1.67

    • Price / Book

      2.42

    • Price / Earnings

      19.73

    • Forward Div Yield

      0.52%

    • Trailing Div Yield

      0.52%

Login To Show Full Chart

Summary

Fair Value Assessment
Undervalued (14% Discount)
Fair ValueQ284.26UncertaintyHigh
Close Price243.95Mar 13, 2025
Market Closed
₹ 243.95
Price Up by 1.85 | 0.76 %
Trading Information Business Description
Previous Close
243.95
Day Range
242.10 – 253.00
Year Range
145.00 – 449.00
Bid / Ask
—
Market Cap
7.1 Bil
Volume / Average
32.1 k / 36.7 k
Beta (5-Year)
0.53
Shares Outstanding
29.15 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Fermenta Biotech Ltd is engaged in the business of manufacturing and marketing chemicals, bulk drugs, enzymes, pharmaceutical formulations, and environmental solution products and renting and selling properties. It is a manufacturer and supplier of Vitamin D and also supplies Penicillin G Amidase, CAL B Lipase, Polymer Supports, and enzyme technologies. The company operates in two segments that are Property and Bulk Drugs/Chemicals. The majority of the revenue comes from the Bulk Drug/Chemicals segment. Geographically, it caters to both domestic and international markets and generates maximum revenue from the Indian market.
Contact
Ghodbunder Road A -1501, Thane One, DIL Complex, Thane, MH 400610
T +91 2267980888
www.fermentabiotech.com opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Dec 31, 2024
Fiscal Year End
Mar 31, 2025
Employees
558
As of Mar 31, 2024

Key Metrics

Income Statement (in Bil, except ratios)
12/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
4.25 3.33 3.49 3.98 3.77 2.93
Revenue Growth %
23.98% -4.47% -12.33% 7.22% 28.84% -27.64%
Gross Profit
2.77 1.91 1.85 2.33 2.33 2.04
Gross Profit Margin %
65.19% 57.14% 53.08% 58.47% 61.89% 69.60%
Operating Income
0.60 0.09 -0.01 0.39 0.67 0.57
Operating Margin %
14.13% 2.82% -0.20% 9.82% 17.71% 19.50%
EBIT
0.62 0.02 -0.35 0.42 0.64 0.56
EBIT Margin %
14.61% 0.75% -10.00% 10.52% 16.91% 19.07%
EBITDA
0.87 0.27 -0.07 0.67 0.84 0.71
EBITDA Margin %
20.45% 8.16% -1.91% 16.94% 22.30% 24.20%
Net Income
0.36 -0.23 -0.51 0.15 0.46 0.60
Net Profit Margin %
8.46% -7.20% -15.34% 3.78% 11.28% 20.34%
Basic EPS
12.27 -7.99 -17.85 5.35 15.77 20.63
Diluted EPS
12.27 -7.99 -17.85 5.33 15.69 20.53
Normalized EPS
— — — — — —
Total Dividends per Share
1.25 1.25 1.25 2.50 — 2.08
Balance Sheet (in Bil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Total Assets
5.39 5.48 6.36 7.07 6.87 6.14
Total Liabilities
2.53 2.63 3.24 3.35 3.27 3.04
Total Debt
1.25 1.39 2.20 2.39 2.32 2.24
Total Equity
2.86 2.85 3.12 3.71 3.60 3.09
Cash And Cash Equivalents
0.21 0.22 0.35 0.13 0.17 0.08
Working Capital
0.60 0.68 0.44 1.07 1.00 0.89
Shares Outstanding (Bil)
— — 0.03 — — 0.03
Book Value Per Share
— 95.63 104.44 129.00 120.84 105.16
Total Debt To Equity
0.44 0.49 0.70 0.64 0.64 0.72
Cash Flow Statement (in Bil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
0.38 1.05 1.17 0.43 0.63 0.34
Cash From Investing Activities
0.45 -0.15 -0.56 -0.26 -0.42 -0.44
Cash From Financing Activities
-0.73 -0.91 -0.41 -0.22 -0.01 -0.47
Capital Expenditures
— 0.19 0.40 0.37 0.55 0.68
Free Cash Flow
— 0.37 0.11 0.07 0.05 -0.26
Change in Cash
0.11 -0.01 0.20 -0.04 0.20 -0.57

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership


STOCKS
MUTUAL FUNDS
ADITYABIRLAAXISBajajBANDHANBARODABNPBOICANARADSPEDELWEISSFRANKLINTEMPLETONGROWWHDFCHELIOSHSBCICICIIIFLINVESCOITIJMKOTAKLICMahindraManulifeMIRAEMOTILALNAVINipponNJOldBridgePGIMPPFASQUANTQUANTUMSAMCOSBISHRIRAMSUNDARAMTATATAURUSTrustUNIONUTIWhiteOakZERODHA
INSURANCE FUNDS
ABSLAEGONAGEASFEDERALAVIVABAJAJALLIANZBHARTIAXACANARAHSBCORIENTBANKEDELWEISSTOKIOEXIDEFUTUREGENERALIHDFCICICIPRUDENTIALINDIAFIRSTKOTAKMAHINDRALICMAXLIFEPNBMETLIFEPRAMERICARELIANCENIPPONSAHARASBISHRIRAMSTARUNIONDAI-ICHITATAAIA

About Us

Connect With Us

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top